Glucocorticoids are well -known apoptotic agents in certain classes of lymphoid cell malignancies. Reduction of intracellular polyamine levels by use of inhibitors that block polyamine synthesis slows or inhibits growth of many cells in vitro. Several such inhibitors have shown efficacy in clinical trials, though the toxicity of some compounds has limited their usefulness. We have tested the effects of combinations of the glucocorticoid dexamethasone ( Dex ) and two polyamine inhibitors, difluoromethylornithine ( DFMO ) and methyl glyoxal bis guanylhydrazone ( MGBG ), on the clonal line of human acute lymphoblastic leukemia cells, CEM -C7 -14. Dex alone kills these cells, though only after a delay of at least 24 hours. We also evaluated a partially glucocorticoid -resistant c -Myc -expressing CEM -C7 -14 clone. We show that Dex downregulates ornithine decarboxylase ( ODC ), the rate -limiting enzyme in polyamine synthesis. Pretreatment with the ODC inhibitor DFMO, followed by addition of Dex, enhances steroid -evoked kill slightly. The combination of pretreatment with sublethal concentrations of both DFMO and the inhibitor of S -adenosylmethionine decarboxylase, MGBG, followed by addition of Dex, results in strong synergistic cell kill. Both the rapidity and extent of cell kill are enhanced compared to the effects of Dex alone. These results suggest that use of such combinations in vivo may result in apoptosis of malignant cells with lower overall toxicity.
Introduction
The three physiological polyamines -putrescine, spermidine, and spermine -are all positively charged polycations at cellular pH and presumably function as stabilizing agents of RNA, DNA, or negatively charged proteins. Cells regulate polyamine pool sizes through synthesis, active transport, degradation, and interconversions [ 1, 2 ] . The active transport system permits exogenous polyamines to be recruited as needed by the cell [ 3 ] . Polyamines are required for cells to cycle, and these complicated, tightly regulated mechanisms allow cells to adjust polyamine levels constantly as growth dictates [ 4 ] . The rate -limiting enzyme in the polyamine synthetic pathway is ornithine decarboxylase ( ODC ), which is responsible for putrescine synthesis. Spermidine and spermine are produced from putrescine by the actions of S -adenosylmethionine decarboxylase ( AdoMetDC ) and spermidine / spermine synthase. ODC activity is required for cells to proceed into S -phase of the cell cycle [ 5 ] and is under multilevel, strict regulation [ 6, 7 ] . AdoMetDC contributes to the production of spermidine and spermine by facilitating the formation of decarboxylated S -adenosylmethionine, the amino propyl donor for spermidine and spermine synthases. Methyl glyoxal bis guanylhydrazone ( MGBG ), a structural analog of spermidine, is a potent reversible inhibitor of AdoMetDC. Alone, MGBG effectively lowers spermidine and spermine levels while causing an accumulation of putrescine by several mechanisms [ 8 ] .
Because of their importance in many cellular functions, polyamines have long been the focus of research as potential chemotherapeutic agents [ 8 ] . Combinations of difluoromethylornithine ( DFMO ) and MGBG have proven to be more effective at halting cell growth than either drug alone. Synergism between the two has been reported [ 8 -10,11 -13 ] when cells were incubated for a period of time with combinations of the inhibitors which allow polyamine pools to drop. Although in vivo outcomes with the combination have sometimes shown heightened toxicity [ 14 ] , several studies have found the polyamine inhibitor drug combination effective in treatment of cancers in mice and humans [ 9 -11,12,13 ] .
The ability of glucocorticoids to affect cell growth has generated much interest to cancer investigators over the years [ 15 -17,18 ] . We have shown that transcriptional downregulation of the proto -oncogene c -myc is a critical signal in the pathway of the glucocorticoid -evoked apoptosis of CEM cells [ 19, 20 ] . The odc gene contains E box binding sites for c -Myc and is a c -Myc transcriptional target [ 5, 21 ] . We demonstrate here that c -Myc levels are suppressed by glucocorticoids, as well as cellular odc mRNA, protein levels, and ODC activity. Historically, it has been shown that direct inhibition of ODC through the use of DFMO, a specific, irreversible inhibitor of the enzyme, slows cell growth [ 22 ] . In several systems, DFMO reduces putrescine and spermidine levels dramatically through irreversible inhibition of ODC; however, spermine levels show an increase. Spermine has been implicated as a possible salvage polyamine, convertible to the precursor polyamines as the need arises [ 8 ] .
There has been only limited data published on the combination of these inhibitors with glucocorticoids in malignant cells [ 23 ] . This study has centered on the ability of polyamine inhibitors to influence glucocorticoid -induced apoptosis in human lymphoblastic leukemic CEM cells. We report here that the synthetic glucocorticoid dexamethasone ( Dex ) causes a reduction in ODC activity, mRNA, and protein in CEM cells. Treatment of these cells with a combination of low nonlethal concentrations of DFMO and MGBG, followed by Dex, speeds the onset of apoptosis and increases its extent.
Materials and Methods

Cell Culture
The human CCRF -CEM cell line was grown from a patient with acute lymphoblastic leukemia [ 24 ] . The glucocorticoid -sensitive CEM -C7 -14 clone was subcloned from the original, sensitive clone CEM -C7 [ 25 ] . To obtain cMyc -expressing cells, CEM -C7 -14 cells were transfected with pBpuroMycER, which contains the human c -Myc protein fused to the modified ligand -binding domain of the murine estrogen receptor [ 26 ] . Selection in puromycin gave rise to a mass culture of cells partially resistant to Dex; clone CEM -MycER -22 was chosen for use herein. All cells were grown in RPMI 1640 medium ( Cellgro; Media Tech, Herndon, VA ), pH 7.4, with 5% heat -inactivated fetal bovine serum ( FBS ) ( Atlanta Biologicals, Norcross, GA ) at 378C in a humidified atmosphere of 95% air, 5% CO 2 . Subculturing at regular intervals insured logarithmic growth. Viable cell numbers were determined by Trypan blue dye ( SigmaAldrich, St. Louis, MO ) exclusion using a hemacytometer, averaging triplicate counts at each data point. All experiments were initiated at 1Â10 5 cells / ml. All reagents, unless otherwise identified, were from Sigma -Aldrich. Extensive preliminary experiments ( not shown ) indicated that addition of the polyamine pathway inhibitors simultaneously with Dex was less effective than pretreatment with DFMO ( Merrell Dow Pharmaceuticals, Cincinnati, OH ) and MGBG followed by Dex. To find optimum concentrations of the polyamine pathway inhibitors, DFMO was tested between 0.1 and 1.0 mM, and MGBG between 50 nM and 25 M. The most effective and least toxic concentrations proved to be 0.5 mM DFMO and 0. tions. To prepare cell lysates, 6.4Â10 6 cells were pelleted at 250g for 10 minutes, 48C, resuspended once in 48C PBS, repelleted, and suspended in 100 l of 50 mM borate buffer, pH 7.4 ( 50 mM sodium hydroxide, 50 mM boric acid, and 1 mM EDTA ). The samples were lysed by three freeze -thaw cycles of À 808C and then 378C, and debris was pelleted at 12,000 rpm for 10 minutes at 48C in a Beckman Microfuge Lite centrifuge. Protein was removed by precipitation with trichloroacetic acid and centrifugation. The clarified samples were then filtered through a 0.22 -m syringe filter ( Millipore, Bedford, MA ). For analysis, HPLC sample tubes ( Supelco, Bellefonte, PA ) were set up with a mixture of 30 l of 0.2 M borate buffer, pH 9.3, and 10 l of 0.2 M borate buffer, pH 8.8. A 10 -l aliquot of the internal standard ( 1Â10 À 5 M 1,7 -diaminoheptane ) and a 10 -l aliquot of experimental cell lysate were added, followed by a 20 -l aliquot of AccQFluor reagent. The samples were incubated at 558C for 10 minutes before HPLC analysis. A sample volume of 20 l was injected onto the column, and the polyamine profile was characterized using a flow rate of 1 ml / min at 378C, excitation = 250 nm and emission = 395 nm, eluting with AccQTag Eluent A / acetonitrile ( Waters; Burdick and Jackson, Muskegon, MI ) as a linear gradient. All samples were analyzed within 24 hours of derivation. Determination of statistical significance was done using a t -test, and P values of less than .05 were considered significant.
Phosphatidylserine Membrane Eversion
Cell pellets were prepared following the instructions of the Annexin -V -FITC kit from PharMingen ( San Diego, CA ). A 5-l aliquot of Annexin -V -FITC and 10 l of 7 -AAD stain were added to 1Â10 5 cells and incubated in the dark at 258C for 15 minutes. A 400 -l aliquot of binding buffer was added and 20,000 cells were analyzed for Annexin -V ( yellow / green ) and 7 -AAD ( red ) positive cells by flow cytometry using a 488 -nm excitation and a 515 -nm bandpass filter for fluorescein detection and a filter >600 nm for 7 -AAD detection on a FACScan ( Becton Dickinson, San Jose, CA ). Doublets and cell aggregates were gated out and only the singlet cell population was analyzed. . As a control, the cultured cells were treated with vehicle only. In each Dex plus inhibitor -treated sample, 0.5 mM DFMO and 0.5 M MGBG were added 24 hours before Dex. Cell lysates of 1.0Â10 5 cells were evaluated by HPLC and normalized with the internal standard 1,7 -diaminoheptane. In each experiment, each time point was evaluated with a minimum of duplicate independent samples, n = 4 -6. Statistical analyses were done using a t -test, and P values of less than .05 were considered to be significant. Table 1 . cells with impaired depolarized mitochondrial membranes were detected using a 530 -nm filter and viable red cells with a 585 -nm filter.
JC -1 Staining of Depolarized Mitochondrial Membranes
Cell Cycle Evaluation by Propidium Iodide ( PI ) Staining Cells ( 1Â10 6 ) were pelleted at 250g for 10 minutes at 48C
and resuspended one time in 1 ml of 48C PBS / 0.1% sodium Table 2 .
bated in a 378C water bath in the dark for 20 minutes. An equal volume of high salt stain ( 3% polyethylene glycol 8000, 50 g / ml PI, 400 mM sodium chloride, 0.1% Triton X -100 ) was added. The samples were covered and placed at 48C for at least 1 hour in the dark. Sample lots of 20,000 cells were analyzed for DNA content by flow cytometry. Red ( PI ) was detected using a 585 -nm filter. Cells containing subdiploid DNA were not used for determination of percentages in G 1 / G 0 , S, or M phase.
Results
Dex Suppresses ODC
In earlier studies, we had demonstrated that by 4 days of exposure, 1 M Dex substantially kills most CEM -C7 cells [ 30 ] , with DNA fragmentation appearing between 36 and 48 hours [ 31 ] . Due to repression of c -myc transcription, levels of c -myc mRNA begin to be suppressed as early as 1 hour after addition of Dex [ 19, 20 ] . We tested the effect of 1 M Dex alone on ODC levels in CEM -C7 cells over 48 hours. The data of Figure 1 ; A À C demonstrate that ODC activity ( A ), mRNA ( B ), and protein ( C ) were all suppressed, whereas ODC activity remained relatively constant throughout the measured time course in control cells ( Figure 1A ) . ODC mRNA was reduced by 8 hours and strongly so by 16 hours and beyond ( Figure 1B ) . ODC protein levels were clearly reduced as well ( Figure 1C ).
Effects of Dex and Inhibitors of Polyamine Synthesis on Polyamine Levels in CEM Cells
In preliminary control experiments ( not shown ), we established in detail that the levels of each of the three polyamines assayed at 24 -hour intervals remained relatively constant in untreated CEM cells. Further preliminary experiments following the effects of adding DFMO or MGBG singly revealed that DFMO alone reduced putrescine to undetectable levels by 24 hours and spermidine to undetectable levels by 48 hours ( not shown ); MGBG alone dramatically elevated putrescine levels by 48 hours with a marked reduction in spermidine and spermine levels ( not shown ). The combination of both inhibitors, however, effectively lowered the levels of all three polyamines ( Figure 2 ; A and B ). Although this slowed cell growth considerably, it caused little cell death ( Figures  3A and 4G ). We therefore tested the inhibitors in combination with Dex. After preliminary studies comparing the effects of adding the inhibitors and Dex simultaneously or sequentially, we chose the following protocol, which was used for the data in Figures 2 À 7 ). Cultures were divided and treated at time zero with vehicle only ( control ) or 0.5 mM DFMO plus 0.5 M MGBG. Twenty -four hours later, subsets of control and inhibitor -treated cells received 100 nM Dex. Samples for polyamine analysis or viability were taken at several times thereafter. Polyamine data from such experiments on CEM -C7 -14 cells are shown in Figure 2 ; A and B ), demonstrating that after 48 hours of Dex treatment alone, putrescine levels were significantly lowered ( P = .045 ), but there was no statistically significant effect on spermidine or spermine concentrations. Adding Dex 24 hours after both inhibitors caused insignificant effects in addition to those caused by DFMO plus MGBG for 48 hours ( Figure 2A ) . By 72 hours in the inhibitors plus 48 hours in Dex, putrescine levels remained undetectable; spermidine, however, was elevated well over the undetectable levels found after inhibitors alone for the same total time of 72 hours, whereas spermine was increased but not to a significant extent ( Figure 2B ). CEM -MycER -22 is a clone of CEM -C7 -14 that has been stably transfected with an expression vector for c -myc. In these cells, the hybrid MycER protein, which conveys c -Myc functions, is constitutively expressed [ 32 ] . These cells exhibit a marked resistance to cell death after 48 hours in 100 nM Dex, compared to the parental CEM -C7 -14 clone ( Ref. [ 32 ] , also Figure 6 ). To test the dependence of polyamine levels on c -Myc in the face of the drug combinations, we carried out the standard protocol on CEM -MycER -22 cells. The putrescine pool was not elevated significantly in the CEM -MycER -22 cells, compared to the CEM -C7 -14 cells under the control conditions, but the remaining downstream polyamines were elevated ( compare controls, Figure 2 ; A and B with C and D ). DFMO and MGBG reduced polyamine levels, but not as dramatically as in the CEM -C7 -14 cells. In the CEM -MycER -22 cells, Dex alone for 48 hours lowered putrescine significantly ( Figure 2D ), P = .02 but not the other two polyamines, compared to time -matched controls. Comparison of polyamine levels in CEM -MycER -22 cells exposed to inhibitors only with those exposed to inhibitors plus Dex revealed a significant difference in spermidine levels ( Figure 2D ), DF + MG versus DF + MG + Dex, P = .002 ) at 72 hours of treatment. As in CEM -C7 -14 cells, the addition of Dex to the inhibitors in CEM -MycER -22 cells tended to raise spermidine levels at 72 hours, with no effect over that of inhibitors alone on putrescine and spermine ( compare Figure 2 ; B and D ). At both 48 and 72 hours, the levels of spermidine and spermine were greater in the CEMMycER -22 cells receiving DFMO plus MGBG and DFMO plus MGBG plus Dex than in the corresponding wild -type CEM -C7 -14 cells ( Figure 2 ; A versus C; B versus D ). As will be seen below, the higher polyamine levels in CEMMyc -22 cells did not afford strong protection against the three -drug combination.
The Extent and Onset of Apoptotic Cell Death Enhanced by the Combination of Polyamine Pathway Inhibitors and Glucocorticoid
At the concentrations used, the combined effect of DFMO and MGBG was primarily to slow cell growth, lengthening the doubling time from 24 to 48 hours. Figure 3A ) demonstrates the growth -inhibitory effects on the CEM -C7 -14 clone of the two inhibitors together without Dex for 72 hours, 100 nM Dex alone for 48 hours, and that after 72 hours when Dex was added after 24 hours of DFMO plus MGBG. The vehicletreated control cells continued to grow logarithmically through the course of the experiment. Exposure to Dex alone reproducibly caused cell loss beginning only beyond 24 hours and still incomplete at 48 hours ( the time points indicated as 48 and 72 on the abscissa ). This is consistent with earlier, longer time course studies showing the full extent of Dex -evoked apoptosis [ 30, 31 ] . When Dex was added after 1 day of exposure to the polyamine pathway inhibitors, cell loss began earlier than with Dex only and was more extensive during the subsequent 48 hours ( compare in Figure 3A , Á, and Â curves; see also Figure 6 ).
The cell loss seen in Figure 3A caused by the three -drug combination appeared to be apoptotic. Glucocorticoids alone are a well -known cause of lymphoid cell apoptosis, but the consequences of adding the polyamine inhibitors and glucocorticoids have had only limited evaluation [ 23 ] . Morphologically, the cells appeared to shrink, condense, and lyse ( not shown ). Phosphatidylserine eversion to the outer surface of the plasma membrane has been shown to precede loss of cell viability [ 33 ] and can be assayed by Annexin binding. Early apoptotic cells exclude 7 -AAD; therefore, Annexin -positive, 7 -AAD -negative cells have undergone phosphatidylserine membrane eversion, but still have an intact cell membrane. By flow cytometry, with Dex alone, 5% of the cells were Annexin -positive, 7 -AADnegative at 59 hours, 35 hours after addition of Dex ( Figure  3B ) ; but if the cells were first exposed to the polyamine pathway inhibitors for 24 hours, this number increased to 21%.
Both Dex and MGBG have been reported to affect mitochondrial functions adversely [ 34 -36 ] . We therefore tested for this by use of the dye JC -1, which freely enters cells, where it produces a green fluorescence, unless taken up by active mitochondria, which metabolize it to its red, aggregate form. This conversion requires an intact mitochondrial membrane potential, ÁÉ m . Cells that remain green have lost mitochondrial membrane integrity, which causes release of activators of the caspase -3 apoptotic pathway [ 35 ] . By this assay, the polyamine pathway inhibitors at these concentrations had little effect ( Figure 3C ). In Dex alone, no change was seen until 64 hours, after which a sharp drop in cells staining red was seen ( note interval 64 to 72 hours; Figure 3C ). When Dex was added 24 hours after the polyamine pathway inhibitors, a two -stage effect on mitochondria was seen. Starting at 48 hours, intact mitochondrial fluorescence was reduced by 10% to 15%, followed by an even deeper decrease between 59 and 64 hours ( Figure 3C ).
For a third test of apoptosis, CEM -C7 -14 cells treated according to the standard protocol were evaluated by staining their DNA with PI at the 72 -hour time point. Figure 4 and Table 1 show FACScans and percent gated cells from such an experiment. The control panel ( Figure 4A ) illustrates a population of logarithmically growing cells after 72 hours of exposure to vehicle only, with about 98% viability. After 48 hours in 100 nM Dex alone, 24% of the cells had a subdiploid DNA content, typical of apoptosis ( Figure 4B ) and Table 1 ), and among the remaining cells, the percentage in G 1 /G 0 increased to 67%. We have observed [ 30 ] and others have confirmed this accumulation of CEM cells in G 1 /G 0 due to Dex [ 18 ] . After 72 hours, 0.5 mM DFMO, 0.5 M MGBG, or both combined in no case produced more than 13% apoptotic CEM -C7 -14 cells ( Figure 4; C; E; G ) and Table 1 ). DFMO for 72 hours, with Dex as well during the final 48 hours, resulted in somewhat greater numbers of subdiploid cells than with Dex alone for 48 hours ( 30% as compared to 24%; Figure 4 ; B and D and Table 1 ) . By 72 hours, however, the three -drug treatment had killed nearly the entire culture, with extensive DNA breakage ( Figure 4H ).
Pretreatment with Polyamine Pathway Inhibitors Followed by Dex Causes Early Induction of Apoptosis
The sequential combination of polyamine pathway inhibitors, followed by addition of Dex, resulted in a noticeable increase in subdiploid cells compared to that seen after 24 hours of Dex alone. At that time, 18% of the cells receiving the combination contained subdiploid amounts of DNA, compared to 2% after Dex alone for a comparable period ( data not shown ). This acceleration of apoptosis due to the sequential combined treatment is shown by the data in Figures 3; 5 and 6 . In Figure 5 and Table 2 , the time in Dex Figure 7 . PI analyses of CEM -MycER -22cells after three -drug treatment. CEM -MycER -22 cells were treated according to the standard protocol, stained with PI, and analyzed by FACScan after the intervals indicated. The data shown are from one of two experiments, which gave very similar results. The percentages of cells in each compartment are presented in Table 3 , A and B.
required for an equivalent accumulation of PI -stained subdiploid cells is compared after addition of Dex alone ( Figure 5; A and B ) or Dex subsequent to DFMO and MGBG. As the data show, pretreatment with DFMO and MGBG followed by 24 hours of added Dex produces the amount of cell death caused after 40 hours of Dex alone ( Figure 5 ; A versus C ); 35 hours of Dex following the polyamine inhibitors result in kill equivalent to 48 hours of Dex alone ( Figure 5 ; B versus D ). The accelerating effect on reduction of numbers of the leukemic cells is shown by the curves with open symbols in Figure 6 . The combined, sequential treatment results in significantly reduced numbers of cells 24 hours after Dex is added ( triangles ), whereas Dex alone begins to show an effect between 48 and 72 hours after addition ( squares ). Furthermore, the extent of cell loss is greater at each of the time points. In Dex alone, equivalent total cell loss is reached only 1 to 2 days later [ 30 ] .
Constitutive Expression of c -Myc Does Not Protect Against Dex in Polyamine -Depleted Cells
We have shown that expression of the hybrid protein cMycER confers significant resistance of CEM cells to Dexinduced apoptosis. The chimeric gene, Myc -ER, is expressed constitutively in these cells, and the Myc moiety is functional although the ER is not activated by estrogen [ 32 ] . Because the ligand -binding domain of the ER may be activated by nonsteroid effectors, we suspect that some endogenous ligand or interactive pathway chronically activates the chimera. In CEM -MycER -22 cells, the ODC mRNA -lowering effect of Dex alone is blunted but not completely blocked ( data not shown ). To determine whether polyamine pathway manipulation could sensitize cells, which stably produce an active form of c -Myc, we compared the effects of the standard protocol on CEMMycER -22 with those on CEM -C7 -14 cells ( Figure 6 ). Dex alone caused a six -fold reduction in viable CEM -C7 -14 cells 3 days later ( open squares ). CEM -MycER -22 cells identically treated were reduced only 2.5 -fold ( closed squares ), reproducing the protective effect of constitutive c -Myc expression that we have reported [ 32 ] . Pretreatment with DFMO and MGBG for 1 day, followed by 3 days with Dex added, caused extensive additional apoptosis of both CEM clones ( open and closed triangles ). Clearly, the protective effect of MycER expression was largely overcome, although there were somewhat more viable cells remaining after 96 hours in the CEM -MycER -22 flasks than in the CEM -C7 -14 flasks. Figure 7 and Table 3 , A and B show data for CEM -MycER -22 cells stained with PI at two time points after various treatments. Again the protection against Dex alone in these cells is shown ( compare Figure  4 ; Panel B with upper right panel, Figure 7 , and Table 1 with Table 3A ). There were clear synergistic effects, however, between the polyamine inhibitors and Dex on the CEM -MycER -22 cells, and these effects overcame the protection to Dex afforded by constitutive c -Myc expression.
In sum, apoptosis was considerably increased with the three -drug treatment as compared to Dex treatment alone in both CEM -C7 -14 and CEM -MycER -22 cells ( Figures 3A; 4; 6 and 7 and Tables 1 and 3 , A and B ). CEM -C7 -14 cells showed more sensitivity to the three -drug treatment than CEM -MycER -22, but synergy was clearly indicated in both cell lines.
Discussion
As hypothesized, glucocorticoids reduce ODC mRNA levels, protein, and enzymatic activity, in a time sequence consistent with dependence on c -Myc. However, under our experimental conditions, this reduction in activity and content of ODC caused only a 50% reduction in putrescine levels ( the immediate product of ODC ), whereas the downstream polyamines spermidine and spermine increased during the time frame in which Dex proceeded to initiate apoptosis. Thus, we conclude that in this system, a reduction in total polyamine levels is not the key linear consequence of Dex administration that leads to apoptosis. As to why the polyamine levels remained elevated when the rate -limiting enzyme had been sharply reduced, one suggestion is that AdoMetDC remains active, feeding into the polyamine pathway beyond ODC, thus contributing to the formation of the downstream polyamines. Thus, until exhausted, the existing putrescine pool could be used to maintain spermidine and spermine. If the cells act to maintain the downstream polyamine levels ( by whatever mechanism ), it suggests that these must be important and perhaps even protective against the apoptotic process initiated by the glucocorticoid. Consequently, we investigated further the effect of inhibitors of the polyamine pathway alone and in conjunction with Dex.
We first carried out extensive tests on the inhibitors DFMO and MGBG singly, DFMO to inhibit ODC, and MGBG to prevent AdoMetDC production. In experiments not shown here, we found that DFMO slowly decreases the putrescine and spermidine pools, while initially increasing that of spermine, the final product of the pathway. By 48 hours in DFMO alone, putrescine and spermidine were undetectable, whereas spermine had increased somewhat over control levels. After 60 hours or later in DFMO, spermine as well fell to control levels or slightly below. We found that if addition of glucocorticoid was delayed until polyamine pools had been decreased by DFMO, some synergy could be seen in the apoptotic effect. Thus, in our clonal system, we confirm the basic finding of synergism that was described by Choi et al. [ 23 ] , on uncloned CEM cells, though the kinetics and extent of the effect seem to differ in the two related experimental cellular systems. We found it difficult to obtain consistent results, however, with the DFMO plus Dex combination.
Treatment with MGBG has two effects on polyamines. The inhibitor blocks AdoMetDC and therefore the subsequent amino propyl additions to the pathway. It is also known that MGBG blocks the transport system through which spermine and spermidine enter the cell. In addition, MGBG can cause mitochondrial damage [ 36 ] . This effect is closely dose -dependent. Consequently, we conducted extensive preliminary studies to find the minimum effective concentration of MGBG that in combination with DFMO would reduce polyamine levels without causing overt cell death. We found this concentration to be approximately 0.5 M, a level of the order of magnitude that in mouse leukemic L1210 cells has been shown to cause only slight mitochondrial swelling [ 36 ] . In our CEM -C7 -14 cells, tests with the dye JC -1 indicated that the combination of 0.5 M MGBG and 0.5 mM DFMO had no effect on mitochondrial integrity for up to 72 hours ( Figure 3C ) and only a slight effect after 96 hours.
Studies in which the polyamine pathway inhibitors were added simultaneously with Dex showed weak synergism at the times we investigated. The two polyamine pathway inhibitors, singly or combined, caused only a sustained low level of apoptosis. However, addition of the inhibitors long enough to cause significantly lowered polyamines, followed by Dex, resulted in marked synergy. This was seen both as a more rapid onset of apoptosis and as more extensive cell death. We find a general correlation between lowered polyamine levels and enhanced sensitivity to Dex. However, CEM -MycER -22 which we engineered to maintain c -Myc and therefore ODC, showed less reduction of polyamines but only modest -if any -protection against the threedrug combination. Together, our results suggest that a chronic effect of treatment by DFMO and MGBG is to make the cells more sensitive to the glucocorticoid Dex. Lowering total cellular polyamine levels does not seem to be the entire explanation for this synergy. It may be that organellespecific polyamine reductions or nonpolyamine related effects are relevant. It has been proposed, for example, that the critical apoptotic action of Dex is to cause a loss of mitochondrial membrane integrity [ 34, 35 ] . Thus, the reduction in cell polyamines, and in particular that of mitochondrial polyamines due to MGBG [ 37 ] , may make those organelles particularly susceptible to Dex. In CEM -MycER -22 cells, MGBG could have a disproportionate effect on mitochondrial polyamines undetectable in the total polyamine pool. It is also possible that other mechanisms account for the lack of protection in these cells. The mechanism of the Dex effect on mitochondria is unknown, though it presumably requires synthesis of both RNA and protein because blocking these processes protects lymphoid cells from glucocorticoid -induced apoptosis [ 17, 38 ] . Thus, MGBG, together with DFMO, in a time -dependent manner, renders mitochondria and cells more susceptible to the apoptosis consequent on the altered gene expression induced by Dex.
Many preclinical and clinical cancer trials of DFMO, MGBG, and the combination have been conducted over the years, with varying degrees of success. DFMO and Dex are considered to be relatively nontoxic [ 39, 40 ] . MGBG originally showed promise in clinical trials, but was temporarily abandoned due to toxicity [ 41, 42 ] . After pharmacokinetic studies showed it to have an extraordinary long half -life in vivo, new dose schedules allowed MGBG to return to clinical usage [ 41, 42 ] . In recent phase II trials, the drug showed potential, with little toxicity against AIDS -related lymphoma [ 43 ] . DFMO and MGBG, in combination, have been shown to be effective in preclinical and clinical trails, though care must be taken in dosage and schedules if undue toxicity is to be avoided [ 41, 42 ] . Our three -drug combination in vitro suggests that due to the synergy between the polyamine pathway inhibitors and Dex, use of lower, less toxic amounts of MGBG may be possible. MGBG dosage seems to be the main factor in using the polyamine inhibitor drug combination effectively. We show that a subtoxic concentration of MGBG is effective when combined with DFMO plus Dex. This concentration of MGBG does not cause the mitochondrial membrane to depolarize significantly compared to untreated controls ( Figure 3C ). The low level of toxicity due to the polyamine pathway inhibitors alone, seen in CEM -C7 -14 cells, is not present in CEM -MycER -22 cells, indicating that at those concentrations, the inhibitors themselves are not an indiscriminate cause of cell death and that the higher polyamine levels in these cells may afford protection ( see Figures 4G and 7 ) Rizzo et al. [ 43 ] were able to estimate tissue levels of MGBG from one patient with AIDS -related non -Hodgkin's lymphoma who had been treated on a schedule of 600 mg / m 2 MGBG intravenously on days 1 and 8. Two days after the day 8 dose, the patient expired and his tissues were analyzed [ 43 ] . On a microgram -of -MGBGper -gram -of -tissue -wet -weight basis, it can be calculated that the tissue concentrations were of the same order of magnitude as those used herein. It is possible that appropriate protocols of these three drugs may provide a combined chemotherapeutic response of value in certain lymphoid malignancies. The combined data from our studies suggest that the lethal pathway evoked by glucocorticoids does not employ lowering of polyamines as a necessary and sufficient step. However, polyamines are protective against Dex, and preliminary administration of DFMO and MGBG renders cells more sensitive to the lethal effect of the glucocorticoid. Regardless of precise mechanism, our data suggest the possibility that the three drugs employed here might prove a potent combination in therapeutic circumstances.
